
Am J Psychiatry 161:1916-1918, October 2004
© 2004 American Psychiatric Association
Comparison of Cortical 5-HT2A Receptor Binding in Bulimia Nervosa Patients and Healthy Volunteers
Ingeborg Goethals, M.D.,
Myriam Vervaet, Ph.D.,
Kurt Audenaert, M.D., Ph.D.,
Christophe Van de Wiele, M.D., Ph.D.,
Hamphrey Ham, M.D., Ph.D.,
Marleen Vandecapelle, M.Sc.,
Guido Slegers, Pharm.Dr.Sc., Ph.D.,
Rudi Dierckx, M.D., Ph.D., and
Cees van Heeringen, M.D., Ph.D.
OBJECTIVE: Bulimia nervosa has been associated with alterations in central serotonergic (5-HT) function. This study investigated iodine-labeled 4-amino-N-[1-[3-(4-fluorophenoxy) propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide (123I-5-I-R91150) binding to the 5-HT2A receptor in the brain by using single photon emission computed tomography in acutely ill bulimia nervosa patients. METHOD: Cortical 123I-5-I-R91150 binding in 10 normal-weight patients with bulimia nervosa, purging type, was compared with that of 11 healthy volunteers. RESULTS: The 5-HT2A binding index of the bulimia nervosa patients, with and without correction for age, was not significantly different from that of the comparison group. CONCLUSIONS: As a group, acutely ill bulimia nervosa patients cannot be discriminated from healthy subjects on the basis of cortical 123I-5-I-R91150 binding to the 5-HT2A receptor.
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Catafau, M. Danus, S. Bullich, J. Llop, J. Perich, V. J. Cunningham, P. Plaza, M. M. Penengo, J. L.H. Eersels, L. Squassante, et al.
Characterization of the SPECT 5-HT2A Receptor Ligand 123I-R91150 in Healthy Volunteers: Part 1--Pseudoequilibrium Interval and Quantification Methods
J. Nucl. Med.,
June 1, 2006;
47(6):
919 - 928.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|